MVIR — Medivir AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK347.33m
- SEK204.53m
- SEK7.63m
Annual cashflow statement for Medivir AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -123 | -42.6 | -62.6 | -88.8 | -89.3 |
| Depreciation | |||||
| Non-Cash Items | -18.3 | -17 | 0 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13.7 | -2.9 | 11.3 | -15.6 | 26.4 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -148 | -58.1 | -48.7 | -102 | -59.7 |
| Capital Expenditures | -1.44 | -2.68 | 0 | -0.382 | -0.261 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.93 | 8.05 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 4.49 | 5.37 | 0 | -0.382 | -0.261 |
| Financing Cash Flow Items | -6.66 | -12.7 | -24.1 | 0.001 | -15.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.66 | -12.1 | 199 | -1.53 | 112 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -152 | -64.5 | 151 | -104 | 52.1 |